EUVIMEDEUVIMED entdecken
Crossref

Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients

Nasim Bolouri, Reza Mansouri, Elham Farhadi, Samaneh Soltani, Maryam Akhtari, Elham Madreseh, Seyedeh Tahereh Faezi, Saeideh Jafarinejad-Farsangi, Ahmadreza Jamshidi, Mahdi Mahmoudi iD

Lupus · 2024

DOI: 10.1177/09612033241276280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lupus, 2024. Verfasst von Nasim Bolouri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Hauptthemen laut MEDLINE: Survivin, Lupus Erythematosus, Systemic, MicroRNAs, Leukocytes, Mononuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services, Shahid Sadoughi University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic lupus erythematosus is a multisystemic rheumatic disease with different clinical features. Disturbance in apoptosis regulation seems to be a major factor in SLE development.

Objective

Survivin plays a key role in mitosis and inhibiting apoptosis. A study was conducted to examine the expression level of survivin and miRNAs that affect survivin transcript levels in patients with SLE.

Methods

We isolated peripheral blood mononuclear cells from 50 inactive SLE patients and 50 healthy controls. RNA is extracted and converted to cDNA. The quantitative real‐time polymerase chain reaction is conducted to assess the expression levels of survivin total and its variants with effective miRNAs in PBMCs.

Results

Expression levels of miR-34a-5p (fold change = 1.5, p ++ = 0.027), and 218-5p (fold change = 1.5, p ++ = 0.020) were significantly increased. While miR-150-5p (fold change = 0.56, p ++ = 0.003) was significantly decreased. The mRNA expression of survivin-WT (fold change = 0.63, p+ + = 0.002) was significantly downregulated in SLE patients compared to the healthy controls. Survivin total and its two major variants (survivin-2B, and survivin-ΔEx3) did not differ significantly between SLE patients and controls.

Conclusion

Although survivin-TS and its two variants (survivin-2B, and survivin-ΔEx3) were not differently expressed in SLE patients, survivin-WT had altered expression. Despite aberrant miRNA expression in PBMCs from SLE patients, survivin and miRNA expression were not associated with leukopenia. The pathogenesis of SLE disorder might be linked to survivin’s other roles in the immune system aside from anti-apoptotic functions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SurvivinLupus Erythematosus, SystemicMicroRNAsLeukocytes, MononuclearHumansFemaleAdultCase-Control StudiesMaleMiddle AgedApoptosisDown-RegulationYoung AdultGene Expression RegulationRNA, MessengerReal-Time Polymerase Chain Reaction

Stichwörter der Autor:innen

ApoptosismicroRNAsurvivinsystemic lupus erythematosus

Substanzen

SurvivinMicroRNAsRNA, MessengerBIRC5 protein, humanMIRN34 microRNA, humanMIR150, human

Autor:innen und Institutionen

  • Immunology Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Research Center for Chronic Inflammatory Diseases, Tehran University of Medical Sciences, Tehran, Iran.
  • Tobacco Prevention and Control Research Center (TPCRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

ORCID-Profile: Mahdi Mahmoudi

Förderung

  • Tehran University of Medical Sciences and Health Services
  • Shahid Sadoughi University of Medical Sciences

Zitieren

APA

Bolouri, N., Mansouri, R., Farhadi, E., Soltani, S., Akhtari, M., Madreseh, E., Faezi, S. T., Jafarinejad-Farsangi, S., Jamshidi, A., & Mahmoudi, M. (2024). Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients. Lupus. https://doi.org/10.1177/09612033241276280

Vancouver

Bolouri N, Mansouri R, Farhadi E, Soltani S, Akhtari M, Madreseh E, et al. Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients. Lupus. 2024. doi:10.1177/09612033241276280

BibTeX
@article{Bolouri2024,
  author = {Bolouri, Nasim and Mansouri, Reza and Farhadi, Elham and Soltani, Samaneh and Akhtari, Maryam and Madreseh, Elham and Faezi, Seyedeh Tahereh and Jafarinejad-Farsangi, Saeideh and Jamshidi, Ahmadreza and Mahmoudi, Mahdi},
  title = {Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients},
  journal = {Lupus},
  year = {2024},
  doi = {10.1177/09612033241276280}
}
Kostenlos starten →